Evidence map›Paper›PMID 40014251›Full record

ArticleNeurochemical research2025

Corydaline Alleviates 1-Methyl-4-Phenylpyridium (MPP

Yabin Song, Chen Yu, Yong Wang, Xiumei Bai, Diangui Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yabin SongDepartment Of Neurology, Xiangan Hospital of Xiamen University, Xiamen, Fujian, China.
Chen YuDepartment Of Neurology, Xiangan Hospital of Xiamen University, Xiamen, Fujian, China.
Yong WangLogistics Support Department, Xiangan Hospital of Xiamen University, Xiamen, Fujian, China.
Xiumei BaiPharmaceutical Department, Zhongshan Torch Development Zone Hospital, Zhongshan, Guangdong, China.
Diangui ZhouDepartment of Neurology, Zhongshan Torch Development Zone Hospital, No.123, Yixian Road, Torch Development Zone, Zhongshan City, Guangdong Province, China. 15604590808@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corydaline (Cory) is a naturally extracted acetylcholinesterase inhibitor. In this study, we aimed to explore the possible roles and functions in Parkinson's disease (PD) using 1-methyl-4-phenylpyridium (MPP

Indexed as

1-Methyl-4-phenylpyridiniumBerberine AlkaloidsNeuroblastomaApoptosisCell Line, TumorCell ProliferationFerroptosisHeme Oxygenase-1HumansNF-E2-Related Factor 2Phospholipid Hydroperoxide Glutathione PeroxidaseSignal TransductionTumor Suppressor ProteinsUbiquitin Thiolesterase1-Methyl-4-phenylpyridiniumBerberine AlkaloidsHeme Oxygenase-1HMOX1 protein, humanNFE2L2 protein, humanNF-E2-Related Factor 2Phospholipid Hydroperoxide Glutathione PeroxidaseTumor Suppressor ProteinsUbiquitin ThiolesteraseCoryFerroptosisGPX4HO-1MPP+NRF2SK-N-SH cells

Identifiers

PMID40014251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.